Skip to content
2000
Volume 18, Issue 1
  • ISSN: 2589-9775
  • E-ISSN: 2589-9783

Abstract

Introduction

A lung condition in which the passage of air into the lungs is obstructed, is treated using a combination pharmaceutical aerosol (Pressurised Metered dosage Inhaler) dosage form, such as Levosalbutamol Sulphate (LS) and Ipratropium Bromide (IB) pressurized inhalation, which contains 50 μg and 20 μg, respectively. Aerodynamic particle size distribution (APSD) aids in comprehending the likelihood of particle deposition in the lungs. In addition to being crucial for the efficacy and safety of medications, the respirable fraction is a significant critical quality attribute (CQA) for nasal and orally inhaled medicinal formulations.

Aims

The evaluation of respirable fraction utilizing Next Generator Impactor (NGI) simulates drug particle deposition in the patient's lungs. The current study used a sensitive high-pressure liquid chromatography technique to assess the deposited respirable fraction through APSD from NGI, as aerodynamic properties of the delivered dosage.

Materials and Methods

The samples are subjected to NGI and analyzed on an X-bridge C18 (50 x 4.6), 3.5 mm with 35°C column oven, volume of injection 100 mL, and 0.5 mL per min flow rate using a mobile phase that is a 75:25% v/v combination of Heptane sulphonic acid sodium salt buffer and Acetonitrile in high-pressure liquid chromatography. The designed approach was validated for its anticipated function and determined the respirable fraction of the delivered dose.

Results and Discussion

The respirable fraction (fine particle dose) in μg for Levosalbutamol sulfate and Ipratropium bromide were observed 27.644 ± 1.9 and 11.045 ± 1.8, respectively. The fine particle fraction in percentage for Levosalbutamol sulfate and Ipratropium bromide were observed 55 ± 1.8 and 56 ± 1.8, respectively. There is no method reported for the determination of Levosalbutamol sulphate and Ipratropium bromide from respirable fraction.

Conclusion

The reliable results generated by novel combined evaluation of LS and IB respirable fractions - correspond to lung deposition in a clinical study, which is about ≤ 5mm particle size in given doses of LS and IB inhalers.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdrr/10.2174/0125899775352741250309005146
2026-03-08
2026-02-23

  • From This Site

    /content/journals/cdrr/10.2174/0125899775352741250309005146
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ZhangR. HuJ. DengL. Aerosol characteristics and Physico-Chemical compatibility of Combivent® (Containing Salbutamol and Ipratropium bromide) mixed with three other inhalants: Budesonide, beclomethasone or N-Acetylcysteine.Pharmaceutics20201217810.3390/pharmaceutics12010078 31963493
     [Google Scholar]
  2. de KruijfW. EhrhardtC. Inhalation delivery of complex drugs — The next steps.Curr. Opin. Pharmacol.201736525710.1016/j.coph.2017.07.015 28846876
     [Google Scholar]
  3. NewmanS.P. Drug delivery to the lungs: Challenges and opportunities.Ther. Deliv.20178864766110.4155/tde‑2017‑0037 28730933
     [Google Scholar]
  4. KumarR. MehtaP. ShankarK.R. Nanotechnology-assisted metered-dose inhalers (MDIs) for high-performance pulmonary drug delivery applications.Pharm. Res.202239112831285510.1007/s11095‑022‑03286‑y 35552983
     [Google Scholar]
  5. AriA. FinkJ.B. Inhalation therapy in patients with tracheostomy: A guide to clinicians.Expert Rev. Respir. Med.201711320120810.1080/17476348.2017.1289843 28228052
     [Google Scholar]
  6. TalaatM. SiX. XiJ. Effect of MDI actuation timing on inhalation dosimetry in a human respiratory tract model.Pharmaceuticals (Basel)20221516110.3390/ph15010061 35056118
     [Google Scholar]
  7. Levosalbutamol: Uses, Interactions, Mechanism of action.2017Available from: https://go.drugbank.com/drugs/DB13139
  8. Levosalbutamol sulphate, Indian Pharmacopoeia. 8th ed. Gaziabad: Indian Pharmacopoeia Commission2018p. 2433
     [Google Scholar]
  9. Ipratropium: Uses, Interactions, Mechanism of action.2017 Available from: https://go.drugbank.com/drugs/DB00332
  10. Ipratropium bromide, Indian Pharmacopoeia. 8th ed. Gaziabad: Indian Pharmacopoeia Commission2018p. 2305
     [Google Scholar]
  11. GondhaleP.S. DeshmukhM.J. OmaseR.V. Comparative evaluation of fine particle fraction and T2 fraction by using next generation impactor (NGI) and glass twin impinger (GTI) on formoterol fumarate and tiotropium dry powder inhaler (DPI) marketed products.Pharm. Chem. J.202256572072610.1007/s11094‑022‑02700‑4
     [Google Scholar]
  12. XuH. TongL. GaoP. Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis.PLoS One2021162e023762010.1371/journal.pone.0237620 33621253
     [Google Scholar]
  13. IramainR. Castro-RodriguezJ.A. JaraA. Salbutamol and ipratropium by inhaler is superior to nebulizer in children with severe acute asthma exacerbation: Randomized clinical trial.Pediatr. Pulmonol.201954437237710.1002/ppul.24244 30672140
     [Google Scholar]
  14. USP 44 and NF 39. United State pharmacopoeia commission202148pp. 124
     [Google Scholar]
  15. European pharmacopoeia.9th edStrasbourgEuropean Directorate for the Quality of Medicines and Healthcare2017
     [Google Scholar]
  16. Stationary Office Books. United Kingdom: British Pharmacopoeia Commission20201pp. 1121-3
     [Google Scholar]
  17. BansodeA. PatilR. GaikwadS. ShettiP. Development and validation of stability indicating method for Ipratropium bromide by using RP-HPLC.INDIAN DRUGS2020572707210.53879/id.57.02.11701
     [Google Scholar]
  18. MusmadeB. SanatanP. LokhandeS. KulkarniS. BhopeS. PadmanabhanS. Development and validation of stability-indicating RP-HPLC method for the simultaneous estimation of Xylometazoline hydrochloride and Ipratropium bromide from nasal spray dosage form.Future J. Pharm. Sci.20217110.1186/s43094‑021‑00247‑x
     [Google Scholar]
  19. AlmalkiA.H. RamzyS. AlmrasyA.A. Development and validation of analytical methods for selective determination of albuterol and budesonide in Airsupra inhalation aerosol using spectrophotometry.Sci. Rep.20231311658710.1038/s41598‑023‑42766‑y 37789024
     [Google Scholar]
  20. HarpsL.C. BizjakD.A. GirreserU. Quantitation of formoterol, salbutamol, and salbutamol-4′-o-sulfate in human urine and serum via UHPLC-MS/MS.Separations202310736810.3390/separations10070368
     [Google Scholar]
  21. HaihuaG. RuiZ. LiangjunD. MengL. ShaL. SuqingZ. HPLC-UV/VIS for determination of ipratropium bromide mixed with salbuterol, beclomethasone propionate and budesonide using dual wavelength-detection method.Drug Res.202373633534010.1055/a‑2007‑1820 36736353
     [Google Scholar]
  22. ChenY. DuS. ZhangZ. Compatible stability and aerosol characteristics of atrovent® (Ipratropium Bromide) mixed with salbutamol sulfate, terbutaline sulfate, budesonide, and acetylcysteine.Pharmaceutics202012877610.3390/pharmaceutics12080776 32824123
     [Google Scholar]
  23. GaikwadS. ShindeM. PatilM. AdatP. Analytical method development and validation of uv spectrophotometric method for simultaneous estimation of ipratropium bromide and levosalbutamol in combined respule formulation.Int J Pharm Res Appl2022741843185010.35629/7781‑070418431850
     [Google Scholar]
  24. RajS. JamakandiV. JalalpureS. RonadP. Simultaneous detection and quantification of bronchodilators in pure form and from in-vitro drug release of a novel combinational formulation.J. Appl. Pharm. Sci.202010813113810.7324/japs.2020.10815
     [Google Scholar]
  25. TongF. ZhouY. XuY. Supramolecular nanomedicines based on host–guest interactions of cyclodextrins.Exploration2023342021011110.1002/EXP.20210111 37933241
     [Google Scholar]
  26. YangW. ZhangW. ChenJ. ZhouJ. Mono-functionalized pillar[n]arenes: Syntheses, host–guest properties and applications.Chin. Chem. Lett.202435110874010.1016/j.cclet.2023.108740
     [Google Scholar]
  27. YanM. WuS. WangY. Recent progress of supramolecular chemotherapy based on Host–Guest interactions.Adv. Mater.20243621230424910.1002/adma.202304249 37478832
     [Google Scholar]
  28. LiuL. XiongM. RongQ. ZhangM. ZhangX.B. Nucleic acid sensors in vivo: Challenges and opportunities.VIEW2023432022006410.1002/VIW.20220064
     [Google Scholar]
  29. YanM. WangY. ChenJ. ZhouJ. Potential of nonporous adaptive crystals for hydrocarbon separation.Chem. Soc. Rev.202352176075611910.1039/D2CS00856D 37539712
     [Google Scholar]
  30. ChenJ. ZhangW. YangW. Separation of benzene and toluene associated with vapochromic behaviors by hybrid[4]arene-based co-crystals.Nat. Commun.2024151126010.1038/s41467‑024‑45592‑6 38341431
     [Google Scholar]
  31. DaiY. SunJ. ZhangX. Supramolecular assembly boosting the phototherapy performances of BODIPYs.Coord. Chem. Rev.202451721605410.1016/j.ccr.2024.216054
     [Google Scholar]
  32. Q2A and Q2B, Text on Validation of Analytical Procedures and Validation of Analytical Procedures: Methodology. International Conference on Harmonization. Geneva,1994
     [Google Scholar]
  33. HandaU. MalikA. GuarveK. JanF. NagpalK. Isocratic RP-HPLC method development, validation, and optimization of BCS-II in bulk and dosage form.Curr. Pharm. Anal.2024201374510.2174/0115734129283491240103071614
     [Google Scholar]
  34. ShahN.T. DhalaniN.J. Determination of four novel process-related genotoxic impurities in Olmesartan medoxomil tablet by RP-HPLC.Rasayan J. Chem.20231631543155210.31788/RJC.2023.1638443
     [Google Scholar]
  35. QiuH. YuC. ChengY. Simultaneous determination of koumine and gelsemine in human plasma using HPLC-UV assay and its clinical application.Curr. Pharm. Anal.201915664064910.2174/1573412915666190222161942
     [Google Scholar]
  36. RaoP.V. RaoN.S. SahooB.M. BabuN.R. Rapid development and validation of atoltivimab, maftivimab and odesivimab in pharmaceutical dosage form by using the rp-hplc method.Curr. Pharm. Anal.202420321222310.2174/0115734129300296240416070559
     [Google Scholar]
  37. PanchalJ. DhadukB. DhalaniJ. Stability indicating isocratic RP-HPLC and second derivative UV spectroscopic methods for simultaneous determination of Remogliflozin etabonate and Vildagliptin hydrochloride.Rasayan J. Chem.202316257958710.31788/RJC.2023.1628212
     [Google Scholar]
  38. PanchalJ. DhalaniJ. Novel ultra-fast liquid chromatography method for simultaneous quantification of metformin hydrochloride and Remogliflozin etabonate.Asian J. Chem.20233592055206010.14233/ajchem.2023.27910
     [Google Scholar]
  39. SinghR. DhadukB. DhalaniJ. A rapid quantification method for simultaneous determination of pendimethalin and metribuzin contents in suspoemulsion formulation.Results in Chemistry.2023510077910.1016/j.rechem.2023.100779
     [Google Scholar]
  40. SinghR. DhalaniJ. A simple and quick run time RP-HPLC technique for combined analysis of Sulfentrazone and Clomazone herbicides.Rasayan J. Chem.202316042154216210.31788/RJC.2023.1648441
     [Google Scholar]
  41. ShahT. KapadiyaK. DhalaniJ. Isolation, characterization and cumulative quantification approach for nine organic impurities in empagliflozin and linagliptin drugs.Indian J. Chem. Technol.202431478210.56042/ijct.v31i3.4234
     [Google Scholar]
  42. DewaniA.P. VekariyaH.J. Optimization of high-performance liquid chromatographic method using central composite design for the simultaneous estimation of ciprofloxacin and loteprednol.J. Chromatogr. Sci.202361327928710.1093/chromsci/bmac016 35237804
     [Google Scholar]
/content/journals/cdrr/10.2174/0125899775352741250309005146
Loading
Evaluation of Respirable Fraction by using Next Generation Impactor of Levosalbutamol Sulphate and Ipratropium bromide Metered Dose Inhaler
Current Drug Research Reviews 18, 137 (2026); https://doi.org/10.2174/0125899775352741250309005146
/content/journals/cdrr/10.2174/0125899775352741250309005146
/content/journals/cdrr/10.2174/0125899775352741250309005146
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): Aerodynamic; HPLC; inhaler; ipratropium bromide; levosalbutamol sulphate; pulmonary; respirable

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test